Clinical Trial Update: CYT003-QbG10 for Treatment of Allergic Asthma Bronchial [Phase 2]

View source ↗

Summary

Phase 2 trial of CYT003-QbG10 for allergic bronchial asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CYT003-QbG10

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Allergic Bronchial Asthma | Phase 2 | Status: COMPLETED